Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Fate Therapeutics (NQ: FATE ) 4.400 +0.130 (+3.04%) Streaming Delayed Price Updated: 1:20 PM EDT, Jul 22, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Fate Therapeutics < Previous 1 2 3 4 5 6 7 8 9 Next > SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the Firm January 23, 2023 From The Schall Law Firm Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of Investors January 19, 2023 From Glancy Prongay & Murray LLP Via Business Wire 5 Health Care Stocks That Are Diving - And May Rally January 19, 2023 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga Bragar Eagel & Squire, P.C. Is Investigating Phathom, Super Micro, and Fate and Encourages Investors to Contact the Firm January 18, 2023 From Bragar Eagel & Squire Via GlobeNewswire INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of Investors January 18, 2023 From Law Offices of Howard G. Smith Via Business Wire Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock? January 18, 2023 Johnson & Johnson stock has been struggling to break out of a correction. It formed a cup-shaped pattern that appeared to add a handle but broke down last week. Via MarketBeat Topics Stocks Exposures US Equities The Law Offices of Frank R. Cruz Continues Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of Investors January 17, 2023 From Law Offices of Frank R. Cruz Via Business Wire Over $10 Million Bet On DiamondHead Holdings? Check Out These 4 Stocks Insiders Are Buying January 17, 2023 Although US stocks closed higher on Friday, there were a few notable insider trades. Via Benzinga FATE ALERT: Bragar Eagel & Squire, P.C. is Investigating Fate Therapeutics, Inc. on Behalf of Fate Stockholders and Encourages Investors to Contact the Firm January 11, 2023 From Bragar Eagel & Squire, P.C. Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of Investors January 11, 2023 From Glancy Prongay & Murray LLP Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of Investors January 11, 2023 From Law Offices of Howard G. Smith Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of Investors January 11, 2023 From The Law Offices of Frank R. Cruz Via Business Wire Top 5 Health Care Stocks That May Surge January 10, 2023 The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. Via Benzinga How Is The Market Feeling About Fate Therapeutics? January 09, 2023 Fate Therapeutics's (NASDAQ:FATE) short percent of float has fallen 4.62% since its last report. The company recently reported that it has 20.24 million shares sold short, which is 27.85% of all... Via Benzinga INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Fate Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm January 09, 2023 From The Schall Law Firm Via Business Wire INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Fate Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm January 06, 2023 From The Schall Law Firm Via Business Wire CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC January 06, 2023 Gene-editing stocks have not been immune when it comes to job losses and workforce reductions. Here are a few of the latest. Via InvestorPlace Dow Jumps 700 Points; S&P 500 Rises Over 2% January 06, 2023 U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 700 points on Friday. Via Benzinga Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session January 06, 2023 Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session January 06, 2023 Via Benzinga Nasdaq Gains 1.5%; Fate Therapeutics Shares Plunge January 06, 2023 U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 550 points on Friday. Via Benzinga Stocks That Hit 52-Week Lows On Friday January 06, 2023 During Friday's trading, 71 companies set new 52-week lows. Via Benzinga Greenbrier, Fate Therapeutics, AnaptysBio And Some Other Big Stocks Moving Lower On Friday January 06, 2023 U.S. stocks traded higher, with the Dow Jones gaining more than 500 points on Friday. Here are some big stocks recording losses in today’s session. Via Benzinga Why Is Fate Therapeutics (FATE) Stock Down 62% Today? January 06, 2023 Fate Therapeutics (FATE) stock is falling on Friday after the company announced the termination of its collaboration with Janssen Biotech. Via InvestorPlace Tesla Falls Again, but This Nasdaq Stock Is Truly Plunging January 06, 2023 The Nasdaq Composite once again is underperforming the rest of the market. Via The Motley Fool Fate Therapeutics Ends Collaboration Deal With Janssen, Cuts Staff January 06, 2023 Via Benzinga Dow Rises Over 300 Points; US Adds 223,000 Jobs In December January 06, 2023 U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Friday. Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2023 January 06, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session January 06, 2023 Via Benzinga Amarin To Rally 138%? Here Are 10 Other Analyst Forecasts For Friday January 06, 2023 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.